Bailard’s NeoGenomics NEO Stock Holding History

Bailard’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,300	Closed	-$183K	–	812
2025 Q1	$183K	Buy	+19,300	New	+$241K	﹤0.01%	704
2024 Q2	–	Sell	-13,400	Closed	-$211K	–	784
2024 Q1	$211K	Buy	+13,400	New	+$207K	0.01%	679

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bailard's NEO Position: Q2 2025 in Review

Bailard sold out of NeoGenomics (NEO) in Q2 2025, closing a stake of 19,300 shares — an estimated $183K sold.

Bailard first reported a position in NEO in Q1 2024 and held it in 2 quarters. The position peaked at $211K in Q1 2024. 274 funds tracked by Wall St. Rank hold NEO as of Q2 2025.

Bailard reported no remaining NeoGenomics position as of Q2 2025 after selling out during the quarter.
Bailard sold 19,300 NeoGenomics shares in Q2 2025, an estimated $183K.
Bailard first reported a position in NeoGenomics in Q1 2024 and held it in 2 quarters.
Bailard's NeoGenomics position peaked at $211K in Q1 2024.
274 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2025.

Based on Bailard's 13F filing for Q2 2025, filed 8 Aug 2025.